🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-524871-22-00
Authorised Phase I

Study to assess the relative bioavailability of Neludolat versus YAZ in healthy female subjects.

2025-524871-22-00 · tracked via the Priya Life Science EU tracker
Sponsor
Pevisal Group Farmaceutici S.r.l.
Sponsor type
Laboratory/Research/Testing facility
Therapeutic area
Reproductive and Urinary Physiological Phenomena
Decision date
12/06/2026
Enrollment target
24
Sites
Czechia

Condition studied

Healthy subjects

Eligibility

Age group
18-64 years
Sex
Female
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-524871-22-00 on CTIS ↗ ← All trials in the EU